Being the most widely studied biomarker, CA19-9 is highly significant for diagnosis and assessing tumor stage, resectability, treatment response, and prognosis of patients with PC [ 10 – 13 ].
← all excerpts
Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
1
—
—